SpotitEarly Enters U.S. Market with $20M+ to Revolutionize At-Home Early Cancer Detection
The Company’s Cancer Detection Technology has Achieved a 94 Percent Accuracy Rate, Attracting Top Investors, Researchers, and Academic Medical Centers ENGLEWOOD, N.J.–(BUSINESS WIRE)–SpotitEarly, a biotech startup focused on transforming cancer screening by harnessing the power…